Early detection and diagnosis of many cancers is very challenging. Late stage detection of a
cancer always leads to high mortality rates. It is imperative to develop novel and more …

Therapies directed toward the central nervous system remain difficult to translate into
improved clinical outcomes. This is largely due to the blood–brain barrier (BBB), arguably …

Advanced drug delivery systems (DDS) enhance treatment efficacy of different therapeutics
in a dosage, spatial, and/or temporal controlled manner. To date, numerous chemical-or …

Recent advances in nanotechnology and growing needs in biomedical applications have
driven the development of multifunctional nanoparticles. These nanoparticles, through …

There are two kinds of targeted drug delivery systems:(I) Active targeted drug delivery (smart
drug delivery) based on ligands affiliation to receptors,(II) Passive targeted drug delivery …

Cardiovascular diseases (CVDs) are one of the foremost causes of high morbidity and
mortality globally. Preventive, diagnostic, and treatment measures available for CVDs are …

Microfluidic technologies have a unique ability to control more precisely and effectively on
two-phase flow systems in comparison with macro systems. Controlling the size of the …

The Nanomedicine Revolution - PMC Back to Top Skip to main content NIH NLM Logo Access
keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Preview …

Cancer is among the most dreadful fatal diseases globally, and the efficacy of recent
chemotherapeutic approaches is limited due to many related drawbacks. The major …

Cancer is the second highest cause of death globally, with about 70% of deaths occurring in
low-or middle-income countries, thus calling for efficient cures. Nanotechnology research …